Real-world evidence of the impact of aspirin use on esophageal cancer incidence in Barrett’s esophagus patients
This large, real-world analysis suggests that the concurrent use of aspirin with PPIs is associated with a reduced risk of esophageal cancer in patients with BE.
Authors
- Khaled Elfert (ORCID: https://orcid.org/0000-0001-5554-6252)
- Ismail Elkhattib (ORCID: https://orcid.org/0000-0003-0759-1010)
- Mohamed Abuelazm (ORCID: https://orcid.org/0000-0002-2514-0689)
- Zain A. Sobani (ORCID: https://orcid.org/0000-0003-0217-703X)
- Ahmed Farid Gadelmawla (ORCID: https://orcid.org/0000-0002-5802-2291)
- Houman Rezaizadeh (ORCID: https://orcid.org/0000-0002-1066-5394)
- Ameer Awashra (ORCID: https://orcid.org/0009-0002-5122-8200)
- Mohamed Elnaggar (ORCID: https://orcid.org/0000-0003-4415-2789)
- Mazen Ibrahem (ORCID: https://orcid.org/0009-0000-1920-5442)
Institutions
- West Virginia University (US)
- Hartford Hospital (US)
- University of Connecticut (US)
- Mansoura University (EG)
- An-Najah National University (PS)
- Tanta University (EG)
- University of Nebraska Medical Center (US)
- Menoufia University (EG)
- UConn Health (US)
Publication Details
- Journal
- Baylor University Medical Center Proceedings
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1080/08998280.2025.2583631
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00